登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
BBr3
化学文摘社编号:
分子量:
250.52
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352101
EC Number:
233-657-9
MDL number:
Assay:
≥99%
InChI key
ILAHWRKJUDSMFH-UHFFFAOYSA-N
InChI
1S/BBr3/c2-1(3)4
SMILES string
BrB(Br)Br
vapor density
8.6 (vs air)
vapor pressure
40 mmHg ( 14 °C)
product line
ReagentPlus®
assay
≥99%
color
colorless to amber
bp
~90 °C (lit.)
mp
−46 °C (lit.)
density
2.60 g/mL at 20 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
Boron tribromide is a strong Lewis acid generally employed in the deprotection of -OH and -NH groups. It is a moisture-sensitive liquid, which is also used to cleave esters or ethers into alkyl bromides.
Application
作为反应物可用于制备:
- 药物中间体6-硝基-L-多巴
- 具有空间保护的咔唑基硼烷部分的发光聚苯乙烯衍生物
- 通过Wurtz型还原偶联反应得到高质量的硼掺杂石墨烯
- 巯基-(+)-甲基苯丙胺半抗原,用于合成具有改善表位密度的(+)-甲基苯丙胺结合型疫苗
- 微米级有机分子-DNA杂合结构
- 通过亲电芳香硼化反应形成硼烷复合物
- 5-HT2C受体激动剂
- 具有叔氨基的联苯衍生物,作为β-分泌酶(BACE1)抑制剂以治疗阿尔茨海默病
- 高度近红外区域荧光p-延伸硼氮杂-二吡咯亚甲基部分单元
- 通过甲氧基取代的N-苯乙基酰亚胺的分子内环化形成四氢异喹啉衍生物
在由香豆素支架合成 benzopyrano benzopyran 类化合物的反应中用于裂解芳基甲基醚。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Eye Dam. 1 - Skin Corr. 1A
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
法规信息
新产品
此项目有
Boron Halides
Kirk-Othmer Encyclopedia of Chemical Technology (2003)
Boron Tribromide
Encyclopedia of Reagents for Organic Synthesis, Second Edition (2006)
Qing Zhao et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 203, 472-480 (2018-06-15)
Four homo/heterometallic complexes [Cu3(L)(μ2-OAc)9(CH3OH) 9]·3CHCl3 (1), [Cu2(L)Ca(μ2-NO3)9] (9), [{Cu2(L)Sr(μ2-NO3)9}9]·CH3CH2OH (11) and [Cu2(L)Ba(μ2-OAc)9(OAc)] (14), containing an acyclic naphthalenediol-based ligand H4L, were synthesized and characterized by elemental analyses, IR, UV-Vis, fluorescence spectra, TG-DTA and X-ray crystallography. The complex 1 was obtained by
Tetrahedron Letters, 47, 5909-5909 (2006)
Hui Wang et al.
European journal of medicinal chemistry, 88, 66-73 (2014-09-14)
The pharmacokinetics (PK) and pharmacodynamics (PD) of PT119, a potent Staphylococcus aureus enoyl-ACP reductase (saFabI) inhibitor with a Ki value of 0.01 nM and a residence time of 750 min on the enzyme target, has been evaluated in mice. PT119
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
